共 104 条
[1]
Fan L(2014)Breast cancer in China Lancet Oncol 15 e279-e289
[2]
Strasser-Weippl K(2017)3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) Ann Oncol. 28 3111-1046
[3]
Li J-J(2001)Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol 19 4224-70
[4]
Cardoso F(2002)Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer Br J Cancer 86 1041-567
[5]
Costa A(2002)Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.[J] Cancer 95 681-1281
[6]
Senkus E(2012)Comprehensive molecular portraits of human breast tumours Nature. 490 61-172
[7]
Ja VDH(2018)Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy Breast Cancer Res Treat. 170 559-412
[8]
Cj VDV(2008)Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol. 26 1275-2224
[9]
Julien JP(2014)Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Lancet. 384 164-491
[10]
Chollet P(2003)Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome Br J Cancer. 88 406-176